Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
doi: 10.1038/sj.ijir.3901581
Dig.Dis Sci 2008;53(4):1114-1121
When asked if patients had noticed that attitudes towards them had changed when they had lost weight, 54% or patients surveyed agreed that attitudes towards them had changed, with 49% of those describing reduced weight related stigma, bias or discrimination
doi: 10.1093/ajcn/34.7.1328 189
Incretin-based anti-obesity medications The development of next-generation AOMs, such as incretin-based GLP-1 receptor agonists, offers promising potential for reducing the health impacts of obesity and improving overall public health outcomes
US$ 22.14
US$ 27.77
US$ 25.88
US$ 26.00
US$ 25.80
US$ 20.17
US$ 28.22
